Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Planned Transition To Sirolimus-Based Therapy Versus Continued Tacrolimus-Based Therapy In Renal Allograft Recipients

NCT00895583 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00895583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00895583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Planned Transition To Sirolimus-Based Therapy Versus Continued Tacrolimus-Based Therapy In Renal Allograft Recipients
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2009
Completion date
August 31, 2013
Enrollment
254 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

graft rejection, kidney transplant, renal allograft recipients, renal transplant